ceo istari oncology privately held biotech company licensed rights poliovirus therapy duke said phase 2 study set duke based positive results earlier patient responded combination approach treatment bolognesi co author phase 1 study said company working food drug administration plan additional studies compare poliovirus therapy standard care company concerned glioblastoma patients refuse participate study standard care treatments control arm ineffective stat delivers fast deep tough minded journalism inside science labs hospitals biotech boardrooms political backrooms dissect crucial discoveries examine controversies puncture hype hold individuals institutions accountable introduce power brokers personalities driving revolution human health stories matter july 20 2017 dina